Finch Therapeutics Group (FNCH) Financials
$7.45
As on 01-Jun-2026 09:30EDT
Market cap
$15 Mln
Revenue (TTM)
$6 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Income Statement ($ Mln) |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
0.11
|
0.86
|
18.53
|
7.72
|
10.15
|
|||||
|
Cost of Revenue
|
0.17
|
1.52
|
5.51
|
57.28
|
33.14
|
0.31
|
|||||
|
Gross Profit
|
-0.17
|
-1.41
|
-4.65
|
18.53
|
-25.43
|
9.84
|
|||||
|
Operating Expenses
|
18.69
|
32.59
|
90.47
|
78.52
|
47.16
|
30.98
|
|||||
|
Operating Profit (EBIT)
|
-18.86
|
-34.00
|
-95.12
|
-59.99
|
-39.44
|
-21.14
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-13.88
|
-78.22
|
-114.65
|
-58.16
|
-39.34
|
-20.75
|
|||||
|
Provision for Tax
|
--
|
-3.46
|
-0.95
|
-2.30
|
-0.09
|
-0.35
|
|||||
|
Profit after Tax (Net Income)
|
-13.88
|
-74.75
|
-114.65
|
-55.86
|
-39.25
|
-20.75
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
-114.65
|
-58.16
|
-39.34
|
-20.75
|
Liabilities ($ Mln) |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
9.08
|
22.89
|
95.71
|
202.22
|
-95.72
|
-59.54
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
37.50
|
28.40
|
52.54
|
8.36
|
249.57
|
155.78
|
|||||
|
Current Liabilities
|
3.17
|
4.08
|
14.69
|
14.79
|
11.49
|
7.33
|
|||||
|
Total Liabilities
|
49.75
|
55.37
|
162.94
|
225.37
|
165.34
|
103.57
|
Assets ($ Mln) |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
38.98
|
29.53
|
91.90
|
91.89
|
59.17
|
54.94
|
|||||
|
Current Assets
|
10.77
|
25.85
|
71.04
|
142.55
|
106.16
|
48.63
|
|||||
|
Total Assets
|
49.75
|
55.37
|
162.94
|
225.37
|
165.34
|
103.57
|
|||||
|
Total Debt*
|
27.79
|
30.13
|
52.34
|
6.02
|
1.81
|
143.15
|
|||||
|
Net Current Assets
|
--
|
21.76
|
59.86
|
127.76
|
94.68
|
41.30
|
Cashflow ($ Mln) |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-31.51
|
-74.85
|
-67.13
|
-31.33
|
-17.32
|
|||||
|
Cash Flow from Investing Activities
|
--
|
1.33
|
-2.18
|
-15.92
|
-2.63
|
-0.97
|
|||||
|
Cash from Financing Activities
|
--
|
-16.16
|
14.87
|
119.11
|
91.48
|
53.30
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-8.64
|
-46.55
|
-71.76
|
-35.28
|
-140.47
|
--
|
|||||
|
Cash EPS ($)
|
-8.64
|
-44.76
|
-68.31
|
-33.83
|
-137.64
|
--
|
|||||
|
Adjusted Book Value ($)
|
5.65
|
14.25
|
59.91
|
127.74
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
-19.62
|
-46.85
|
-42.41
|
-112.13
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-19.62
|
-48.22
|
-52.50
|
-121.55
|
--
|
Profitability Ratios |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
-30.88
|
-74.36
|
-64.36
|
-97.72
|
762.47
|
--
|
|||||
|
ROE (%)
|
-86.83
|
-126.06
|
-76.96
|
-104.89
|
50.56
|
--
|
|||||
|
ROA (%)
|
-26.40
|
-68.48
|
-59.05
|
-28.59
|
-29.19
|
--
|
|||||
|
EBIT Margin (%)
|
--
|
-31,777.57
|
-10,243.21
|
-323.68
|
-510.90
|
-208.21
|
|||||
|
Net Margin (%)
|
--
|
-69,863.55
|
-13,315.45
|
-301.42
|
-508.46
|
-204.39
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
-0.88
|
-0.95
|
1.40
|
-0.24
|
--
|
|||||
|
EBIT Growth (%)
|
59.19
|
61.45
|
-47.03
|
-52.11
|
-86.53
|
--
|
|||||
|
Net Profit Growth (%)
|
81.44
|
34.80
|
-105.24
|
-42.32
|
-89.11
|
--
|
|||||
|
EPS Growth (%)
|
0.81
|
0.35
|
-1.03
|
0.75
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-0.08
|
-0.01
|
-0.28
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
0.25
|
0.01
|
0.08
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
--
|
-0.33
|
0.22
|
1.94
|
--
|
--
|
|||||
|
Close Price ($)
|
--
|
3.61
|
14.40
|
299.10
|
--
|
--
|
|||||
|
High Price ($)
|
--
|
18.30
|
328.50
|
675.00
|
--
|
--
|
|||||
|
Low Price ($)
|
--
|
2.96
|
9.00
|
263.10
|
--
|
--
|
|||||
|
Market Cap ($ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
3.06
|
1.32
|
0.55
|
0.03
|
-0.02
|
-2.40
|
|||||
|
Short term debt to equity ratio
|
0.25
|
0.15
|
0.07
|
0.01
|
--
|
--
|
|||||
|
Current Ratio
|
3.39
|
6.33
|
4.84
|
9.64
|
9.24
|
6.64
|
|||||
|
Quick Ratio
|
--
|
--
|
5.08
|
10.25
|
--
|
6.64
|
|||||
|
Interest Coverage
|
--
|
--
|
-2.49
|
-26.07
|
-372.04
|
--
|
Operating Efficiency Ratios |
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
16.72
|
2.67
|
14.19
|
46.74
|
|||||
|
Asset Turnover
|
--
|
0.00
|
0.00
|
0.09
|
0.06
|
--
|
|||||
|
Receivable days
|
--
|
245.78
|
135.32
|
15.66
|
138.19
|
170.72
|
|||||
|
Inventory Days
|
--
|
-844.16
|
-417.28
|
-57.84
|
0.00
|
0.00
|
|||||
|
Payable days
|
303.33
|
148.74
|
160.31
|
20.27
|
18.05
|
761.91
|
|||||
|
Cash Conversion Cycle
|
--
|
-747.13
|
-442.26
|
-62.45
|
120.14
|
-591.19
|